PHASE II STUDY OF GEMCITABINE AND CISPLATIN IN ADVANCED NON-SMALL CELL LUNG CANCER

PHASE II STUDY OF GEMCITABINE AND CISPLATIN IN ADVANCED NON-SMALL CELL LUNG CANCER

Show other versions (1)

Cisplatin-based chemotherapy is the standard treatment for advanced non-small cell lung cancer (NSCLC). Many novel drugs have been used in combination with cisplatin in this setting. Of these drugs, gemcitabine is reported to have a high response rate and acceptable toxicity. The aim of this study w...

Full description

Bibliographic Details
Main Authors: M. Hoseinzadeh Mollayosefy, M. Iravani, A. Ghavamzadeh, G. Toogheh K. Alimoghadam
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2006-04-01
Series:Acta Medica Iranica
Subjects:
Non small cell lung cancer
gemcitabine
cisplatin
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/3146

Internet

https://acta.tums.ac.ir/index.php/acta/article/view/3146

Similar Items